CAR T-CELL THERAPY TO TARGET CD94 IN T/NK CELL MALIGNANCIES

$648,000FY2025Defense Health AgencyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators

View source on USAspending →